$BKYI

Citigroup (NYSE:C) reported Q3 earnings of $2.85 per share, beating estimates. Bumble (NASDAQ:BMBL) surged 56% after a buyout deal. BIO-Key (NASDAQ:BKYI) rose 139% on a government security contract. Fermi (NASDAQ:FRMI) gained 21% on a credit agreement. Pershing Square (NYSE:PS) fell 11% after a downgrade. Cipher Digital (NASDAQ:CIFR) dropped 14% on a convertible notes offering. Syndax (NASDAQ:SNDX) declined 17% after a trial failure. Oil rose 0.4% to $94.13, while gold and silver fell.

The Dow Jones rose 100 points, while the NASDAQ and S&P 500 saw mixed results. Goldman Sachs (GS) reported Q3 earnings of $17.01 per share, beating estimates. Several stocks saw significant price changes, including JBDI, BKYI, and FLYE. Commodities and European/Asian markets also showed varied movements.

BIO-key International (BKYI) appointed Stephen Morrow as President of PortalGuard, its identity and access management platform, replacing retiring Mark Cochran. Morrow brings cybersecurity and enterprise sales experience. The company aims to expand enterprise adoption and partnerships, with its Passkey:YOU technology achieving FIDO certification.

BIO-key International Inc. (BKYI) stock surged 139.39% on news of a strategic partnership with Dubai-based Al Majlis Group, expanding into the UAE and Saudi Arabia. The company also secured FIDO Alliance Certification for its Passkey:YOU authenticator. BKYI reported $5.9M in revenue, negative profit margins, and a current ratio of 1.3. Traders are watching for execution on new contracts and revenue growth.

BIO-key International (BKYI) announced that a Middle East government agency selected its Multi-Factor Authentication and Single Sign-On platform to secure its core communications infrastructure. The deployment, supported by IT Harmony, was completed in under two months, reflecting close collaboration. This adds to BIO-key's growing customer base in the region's government and financial sectors.

BIO-key International (BKYI) announced that stockholders plan to sell 1.24 million shares. The company won't participate or receive proceeds. BKYI's P/S ratio is 0.23, below its historical median of 2.33, reflecting market skepticism. Its GF Score is 50/100, with weak profitability and growth. The company has a market cap of $2M and operates in identity and access management.

BIO KEY INTERNATIONAL INC (BKYI) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. Item 5.07 Submission of Matters to a Vote of Security Holders. On September 3, 2026, BIO-key International, Inc. (the “ Company ”) convened its 2026 Annual Meeting of Stockholders (the “ Annual Meeting ”), which was adjourned until Friday, October 2, 2026 at 10:00 a.m., local tim

BIO-key International exchanged $416,315.80 in debt with Streeterville Capital for 247,805 common shares, retiring the remaining balance of a secured promissory note. The transaction aims to reduce debt and simplify the capital structure, according to the company.

BIO KEY INTERNATIONAL INC (BKYI) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. On September 29, 2026, BIO-key International, Inc. (the “Company”) entered into four separate Exchange Agreements (the “Exchange Agreements”) with Streeterville Capital, LLC (“Lender”), to whom the Company previously issued th

BIO-key International (BKYI) surged 85.71% to $3.12 on September 29th, with a high of $4.66, on news of a partnership with Al Majlis Group to expand its identity security platform in the UAE and Saudi Arabia. The collaboration aims to bring biometric authentication and IAM technology to government and private sector organizations in the region.